Expanding the potential for epigenetic therapies in combination with current standard-of-care therapy for prostate cancer.

Judith Manley, Ian Mills, Simon McDade, David Waugh, Melissa LaBonte Wilson^*

^*Corresponding author for this work

Research output: Contribution to conference › Poster › peer-review

Original language	English
Publication status	Published - 13 Nov 2018
Event	30th EORTC-NCI-AACR Molecular Targets in Cancer Therapeutics - Dublin , Ireland Duration: 13 Nov 2018 → …

Conference	30th EORTC-NCI-AACR Molecular Targets in Cancer Therapeutics
Country/Territory	Ireland
City	Dublin
Period	13/11/2018 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@conference{a80111995ceb46e9bddb4be237eb6e9d,

title = "Expanding the potential for epigenetic therapies in combination with current standard-of-care therapy for prostate cancer.",

author = "Judith Manley and Ian Mills and Simon McDade and David Waugh and {LaBonte Wilson}, Melissa",

year = "2018",

month = nov,

day = "13",

language = "English",

note = "30th EORTC-NCI-AACR Molecular Targets in Cancer Therapeutics ; Conference date: 13-11-2018",

}

TY - CONF

T1 - Expanding the potential for epigenetic therapies in combination with current standard-of-care therapy for prostate cancer.

AU - Manley, Judith

AU - Mills, Ian

AU - McDade, Simon

AU - Waugh, David

AU - LaBonte Wilson, Melissa

PY - 2018/11/13

Y1 - 2018/11/13

M3 - Poster

T2 - 30th EORTC-NCI-AACR Molecular Targets in Cancer Therapeutics

Y2 - 13 November 2018

ER -